Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

4.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.7K
Regulation of Food Intake01:30

Regulation of Food Intake

2.7K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.7K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

5.9K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

6.0K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Streptococcal quorum sensing peptide CSP-7 contributes to muscle inflammation and wasting.

Biochimica et biophysica acta. Molecular basis of disease·2024
Same author

Evaluation of proline-rich antimicrobial peptides as potential lead structures for novel antimycotics against <i>Cryptococcus neoformans</i>.

Frontiers in microbiology·2024
Same author

Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology.

Frontiers in endocrinology·2023
Same author

In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Onc72 Prodrugs.

Advanced healthcare materials·2023
Same author

The bacterial quorum sensing peptide iAM373 is a novel inducer of sarcopenia.

Clinical and translational medicine·2022
Same author

The quorum sensing peptide EntF* promotes colorectal cancer metastasis in mice: a new factor in the host-microbiome interaction.

BMC biology·2022

Related Experiment Video

Updated: Apr 21, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

3.3K

Development of second generation peptides modulating cellular adiponectin receptor responses.

Laszlo Otvos1, Daniel Knappe2, Ralf Hoffmann2

  • 1Department of Biology, Temple University Philadelphia, PA, USA.

Frontiers in Chemistry
|November 5, 2014
PubMed
Summary

Researchers developed peptide ADP399, a potent adiponectin receptor agonist, showing promise for cancer therapy. A novel antagonist, ADP400, was also identified for studying adiponectin's role in cell growth.

Keywords:
antiproliferationbiodistributiondimeric peptidemolecular dynamics simulationsnanomolar activity

More Related Videos

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

17.2K

Related Experiment Videos

Last Updated: Apr 21, 2026

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
09:20

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

3.3K
Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

17.2K

Area of Science:

  • Biochemistry
  • Endocrinology
  • Pharmacology

Background:

  • Adipose tissue functions as an endocrine organ, secreting adipokines like adiponectin.
  • Adiponectin plays a role in energy homeostasis and has implications in various diseases.
  • Previous development of a peptide-based adiponectin receptor agonist (ADP355) for glioblastoma and breast cancer.

Purpose of the Study:

  • To further investigate the effects of peptide ADP355 in additional cellular models.
  • To design and evaluate novel adiponectin receptor modulators based on structural insights.
  • To assess the therapeutic potential and pharmacological properties of developed peptides.

Main Methods:

  • In vitro cell proliferation assays using chronic myeloid leukemia (CML) and breast cancer (BC) cell lines.
  • Molecular modeling to understand peptide structure-activity relationships.
  • Development and testing of a dimeric peptide (ADP399) and an octapeptide antagonist (ADP400).
  • Biodistribution studies to evaluate tissue dissemination after different administration routes.

Main Results:

  • Peptide ADP355 inhibited CML cell proliferation and renal myofibroblast differentiation.
  • The dimeric peptide ADP399 demonstrated significantly enhanced cellular activity (pM-nM IC50 values) against K562 CML and MCF-7 BC cells.
  • Subcutaneous administration showed superior tissue dissemination for both peptides compared to intraperitoneal injection.
  • The octapeptide ADP400 acted as an antagonist, counteracting ADP355/ADP399 effects and inducing mitogenic effects in BC cells.

Conclusions:

  • The dimeric peptide ADP399 exhibits characteristics of a promising peptide drug lead for cancer therapy.
  • The antagonist peptide ADP400 serves as a valuable tool for validating therapeutic targets and studying adiponectin functions.
  • Developed peptides show potential for modulating adiponectin receptor activity in various disease contexts.